Lung transplantation

Lung transplantation
Illustration showing the process of a lung transplant. In figure A, the airway and blood vessels between a recipient's diseased right lung and heart are cut. The inset image shows the location of the lungs and heart in the body. In figure B, a healthy donor lung is stitched to the recipient's blood vessels and airway.
Other names	Pulmonary transplantation
ICD-9-CM	33.5
MeSH	D016040

Lung transplantation, or pulmonary transplantation, is a surgical procedure in which one or both lungs are replaced by lungs from a donor. Donor lungs can be retrieved from a living or deceased donor. A living donor can only donate one lung lobe. With some lung diseases, a recipient may only need to receive a single lung. With other lung diseases such as cystic fibrosis, it is imperative that a recipient receive two lungs. While lung transplants carry certain associated risks, they can also extend life expectancy and enhance the quality of life for those with end stage pulmonary disease.^[1]

Qualifying conditions

Lung transplantation is the therapeutic measure of last resort for patients with end-stage lung disease who have exhausted all other available treatments without improvement. A variety of conditions may make such surgery necessary. As of 2005, the most common reasons for lung transplantation in the United States were:^[2]

• 27% chronic obstructive pulmonary disease (COPD), including emphysema;
• 16% idiopathic pulmonary fibrosis;
• 14% cystic fibrosis;
• 12% idiopathic (formerly known as "primary") pulmonary hypertension;
•   5% alpha 1-antitrypsin deficiency;
•   2% replacing previously transplanted lungs that have since failed;
• 24% other causes, including bronchiectasis and sarcoidosis.

Contraindications

Despite the severity of a patient's respiratory condition, certain pre-existing conditions may make a person a poor candidate for lung transplantation:^[3]

• Concurrent end-stage chronic illness (e.g., congestive heart failure, kidney disease, liver disease)
• Current infections, including HIV and hepatitis - relative contraindications
  • However, more and more often, hepatitis C patients are both being transplanted and are also being used as donors if the recipient is hepatitis C positive. Similarly, select HIV-infected individuals have received lung transplants after being evaluated on a case-by-case basis.^[4]
• Current or recent cancer - depends on estimated survival after the treatment of malignant disease
• Current use of alcohol, tobacco or illegal drugs
• Age - relative contraindication
• Psychiatric conditions
• History of noncompliance with medical instructions

History

Doctors at the Sklifosovsky Institute start a lung transplantation operation. The operation will last about 12 hours.

The history of organ transplants began with several attempts that were unsuccessful due to transplant rejection. Animal experimentation by various pioneers, including Vladimir Demikhov and Henry Metras,^[5] during the 1940s and 1950s first demonstrated that the procedure was technically feasible. James Hardy of the University of Mississippi performed the first human lung transplant on June 11, 1963.^[6][7][8] Following a single-lung transplantation, the patient, identified later as convicted murderer John Richard Russell,^[9] survived for 18 days. From 1963 to 1978, multiple attempts at lung transplantation failed because of rejection and problems with anastomotic bronchial healing (i.e. reconnection of Bronchial passages). It was only after the invention of the heart-lung machine, coupled with the development of immunosuppressive drugs such as ciclosporin, that organs such as the lungs could be transplanted with a reasonable chance of patient recovery.^[10]

The first successful transplant surgery involving the lungs was a heart-lung transplant, performed by Dr. Bruce Reitz of Stanford University in 1981 on a woman who had idiopathic pulmonary hypertension.^[11][12]

• 1983: First successful long-term single lung transplant (Tom Hall) by Joel Cooper (Toronto)^[13]
• 1986: First successful long-term double lung transplant (Ann Harrison) by Joel Cooper (Toronto)^[14]
• 1988: First successful long-term double lung transplant for cystic fibrosis by Joel Cooper (Toronto).

In 1988, Vera Dwyer, a woman from County Sligo in Ireland, was diagnosed with an irreversible, chronic and fibrotic lung disease. Later on that year, she received a single lung transplant in the UK. In November 2018, Ms. Dwyer was recognized as the world's longest surviving single lung transplant recipient in an event at the Mater Hospital in Dublin.^[15][16] She died in 2021, thirty-three years after her transplant.^[17]

Transplant requirements

Requirements for potential donors

There are certain requirements for potential lung donors, due to the needs of the potential recipient. In the case of living donors, this is also in consideration of how the surgery will affect the donor:^[3]

• Healthy
• Size match (mostly based on height)
  • The donated lung or lungs must be large enough to adequately oxygenate the patient, but small enough to fit within the recipient's chest cavity
• Age
• Blood type

Requirements for potential recipients

While a transplant center is free to set its own criteria for transplant candidates, certain requirements are generally agreed upon:^[3]

• End-stage lung disease
• Has exhausted other available therapies without success
• No other chronic end-stage medical conditions (e.g., heart, kidney, liver)
  • Some patients with these diseases, if their condition can be made to improve to the point where they are stable enough to survive the operation, are granted an exception- many individuals with end-stage lung disease will have acute or chronic illnesses in other organs). These patients that are often acutely deteriorating and are critically ill can be successfully "bridged" to transplantation with the use of extracorporeal membrane oxygenation. It can allow patients with acute respiratory failure to improve while waiting and to remain eligible for transplantation.^[18][19]
• No current infections or recent cancer. Some patients, on a case by case basis and based on estimated survival after the treatment of malignant disease, may be allowed after the discussion within multidisciplinary teams. There are also certain cases where pre-existing infection is unavoidable, as with many patients with cystic fibrosis. In such cases, transplant centers, at their own discretion, may accept or reject patients with current infections of B. cepacia or MRSA
• No HIV or hepatitis, although some recipients that are heaptitis C positive can receive a lung from a hepatitis C positive donor, and individuals with HIV who can be stabilized and can have a low HIV viral load may be eligible;
• No alcohol, smoking, or drug abuse (some individuals who can cease these habits and comply with treatment may be allowed after the professional assessment)
• Within an acceptable weight range (marked undernourishment or obesity are both associated with increased mortality)
• Age (single vs. double tx)
• Acceptable psychological profile
• Has a social support system
• Financially able to pay for expenses (where medical care is paid for directly by the patient)
• Able to comply with post-transplant regimen. A lung transplant is a major operation with complex follow-up, and the patient must be willing to adhere to a lifetime regimen of medications as well as continuing medical care.

Medical tests for potential transplant candidates

Patients who are being considered for placement on the organ transplant list undergo extensive medical tests to evaluate their overall health status and suitability for transplant surgery.^[20]

• Blood typing; the recipient's blood type must match the donor's, due to antigens that are present on donated lungs. A mismatch of blood type can lead to a strong response by the immune system and subsequent rejection of the transplanted organs
• Tissue typing; ideally, the lung tissue would also match as closely as possible between the donor and the recipient, but the desire to find a highly compatible donor organ must be balanced against the patient's immediacy of need
• Chest X-ray – PA & LAT, to verify the size of the lungs and the chest cavity
• Pulmonary function tests
• CT Scan (High Resolution Thoracic & Abdominal)
• Bone mineral density scan
• MUGA (Gated cardiac blood pool scan)
• Cardiac stress test (Dobutamine/Thallium scan)
• Ventilation/perfusion (V/Q) scan
• Electrocardiogram
• Cardiac catheterization
• Echocardiogram

Lung allocation score

Main article: lung allocation score

Before 2005, donor lungs within the United States were allocated by the United Network for Organ Sharing on a first-come, first-served basis to patients on the transplant list. This was replaced by the current system, in which prospective lung recipients of age of 12 and older are assigned a lung allocation score or LAS, which takes into account various measures of the patient's health. The new system allocates donated lungs according to the immediacy of need rather than how long a patient has been on the transplant list. Patients who are under the age of 12 are still given priority based on how long they have been on the transplant waitlist. The length of time spent on the list is also the deciding factor when multiple patients have the same lung allocation score.^[21]

Patients who are accepted as good potential transplant candidates must carry a pager with them at all times in case a donor organ becomes available. These patients must also be prepared to move to their chosen transplant center at a moment's notice. Such patients may be encouraged to limit their travel within a certain geographical region in order to facilitate rapid transport to a transplant center.^{[citation needed]}

Types of lung transplant

Lobe

A lobe transplant is a surgery in which part of a living or deceased donor's lung is removed and used to replace the recipient's diseased lung. In living donation, this procedure requires the donation of lobes from two different people, replacing a lung on each side of the recipient. Donors who have been properly screened should be able to maintain a normal quality of life despite the reduction in lung volume. In deceased lobar transplantation, one donor can provide both lobes.^{[citation needed]}

Single-lung

Many patients can be helped by the transplantation of a single healthy lung. The donated lung typically comes from a donor who has been pronounced brain-dead.^{[citation needed]}

Double-lung

Certain patients may require both lungs to be replaced. This is especially the case for people with cystic fibrosis, due to the bacterial colonization commonly found within such patients' lungs; if only one lung were transplanted, bacteria in the native lung could potentially infect the newly transplanted organ.

Heart–lung

Main article: Heart–lung transplant

Some respiratory patients may also have severe cardiac disease which would necessitate a heart transplant. These patients can be treated by a surgery in which both lungs and the heart are replaced by organs from a donor or donors.^{[citation needed]}

A particularly involved example of this has been termed a "domino transplant" in the media. First performed in 1987, this type of transplant typically involves the transplantation of a heart and lungs into recipient A, whose own healthy heart is removed and transplanted into recipient B.^[22]

Procedure

While the surgical details will depend on the type of transplant, many steps are common to all these procedures. Before operating on the recipient, the transplant surgeon inspects the donor lung(s) for signs of damage or disease. If the lung or lungs are approved, then the recipient is connected to an IV line and various monitoring equipment, including pulse oximetry. The patient will be given general anesthesia, and a machine will breathe for him or her.^[23]

It takes about one hour for the pre-operative preparation of the patient. A single lung transplant takes about four to eight hours, while a double lung transplant takes about six to twelve hours to complete. A history of prior chest surgery may complicate the procedure and require additional time.^[23]

Single-lung

Incision scarring from a double lung transplant

In single-lung transplants, the lung with the worse pulmonary function is chosen for replacement. If both lungs function equally, then the right lung is usually favored for removal because it avoids having to maneuver around the heart, as would be required for excision of the left lung.^[3]

In a single-lung transplant the process starts out after the donor lung has been inspected and the decision to accept the donor lung for the patient has been made. An incision is generally made from under the shoulder blade around the chest, ending near the sternum. An alternate method involves an incision under the breastbone.^[2] In the case of a singular lung transplant the lung is collapsed, the blood vessels in the lung tied off, and the lung removed at the bronchial tube. The donor lung is placed, the blood vessels and bronchial tube reattached, and the lung reinflated. To make sure the lung is satisfactory and to clear any remaining blood and mucus in the new lung a bronchoscopy will be performed. When the surgeons are satisfied with the performance of the lung the chest incision will be closed.^{[citation needed]}

Double-lung

A double-lung transplant, also known as a bilateral transplant, can be done either sequentially, en bloc, or simultaneously. Sequential is more common than en bloc.^[3]

The transplantation process starts after the donor lungs are inspected and the decision to transplant has been made. An incision is then made from under the patient's armpit, around to the sternum, and then back towards the other armpit; this is known as a clamshell incision. Another approach can be achieved with bilateral anterior thoracotomies.^[24] Intraoperatively, lung transplantation can be performed with the use of extracorporeal membrane oxygenation, cardiopulmonary bypass (heart-lung machine) or without any mechanical circulatory support. Intraoperative mechanical circulatory support can be required due to severe pulmonary hypertension, haemodynamic instability or inability to tolerate one-lung ventilation.^[25] In the case of a sequential transplant the recipient's lung with the poorest lung functions is collapsed, the blood vessels tied off, and cut at the corresponding bronchi. The new lung is then placed and the blood vessels reanastomosed (reconnected). To make sure the bronchial anastomosis is satisfactory before transplanting the other a bronchoscopy is performed.

Post-operative care

Immediately following the surgery, the patient is placed in an intensive care unit for monitoring, normally for a period of a few days. The patient is put on a ventilator to assist breathing. Nutritional needs are generally met via total parenteral nutrition, although in some cases a nasogastric tube is sufficient for feeding. Chest tubes are put in so that excess fluids may be removed. Because the patient is confined to bed, a urinary catheter is used. IV lines are used in the neck and arm for monitoring and giving medications.^[23] After a few days, barring any complications, the patient may be transferred to a general inpatient ward for further recovery. The average hospital stay following a lung transplant is generally one to three weeks, though complications may require a longer period of time.^[23] After this stage, patients are typically required to attend rehabilitation gym for approximately 3 months to regain fitness. Light weights, exercise bike, treadmill, stretches and more are all a part of the rehabilitation programme. Postoperative rehabilitation is crucial for the outcomes of transplant recipients and has evolved since the late 20th century.^[26]

There may be a number of side effects following the surgery. Because certain nerve connections to the lungs are cut during the procedure, transplant recipients cannot feel the urge to cough or feel when their new lungs are becoming congested. They must therefore make conscious efforts to take deep breaths and cough in order to clear secretions from the lungs.^[27] Their heart rate responds less quickly to exertion due to the cutting of the vagus nerve that would normally help regulate it.^[28] They may also notice a change in their voice due to potential damage to the nerves that coordinate the vocal cords.^[28]

Evidence suggests that exercise may contribute to speeding up physical recovery in adults after lung transplantation, helping to minimize disability from physical inactivity, both pre and post-transplant.^[29] However, there are no detailed guidelines on how exercise should be performed in this type of population.^[29]

The results obtained from a 2021 Systematic Review concluded that the effects of exercise in this population are still very questionable.^[29] While some studies do report benefits taken from exercising, while others have not reached the same conclusions.^[29] Nonetheless, the articles involved in this systematic review reported enhancements in muscle strength and increased bone mineral density as well as improvements in 6MWT.^[29]

Miscellaneous

Post-transplant patients are held from driving for the first 3 months pending an assessment of the patient's capacity to drive; this assessment is usually performed by an occupational therapist. Eyesight, physical ability to do simple actions such as check blind spots, wear a seat belt safely without the wound site being affected and hand eye coordination are all assessed.^{[citation needed]}

Hygiene becomes more important in everyday living due to the immunosuppressant drugs which are required every day to prevent transplant rejection. Lack of a strong immune system leaves transplant recipients vulnerable to infections. Care must be taken in food preparation and hygiene as gastroenteritis becomes more of a risk.^{[citation needed]}

Risks

Micrograph showing lung transplant rejection. Lung biopsy. H&E stain.

As with any surgical procedure, there are risks of bleeding and infection. The newly transplanted lung itself may fail to properly heal and function. Because a large portion of the patient's body has been exposed to the outside air, sepsis is a possibility, so antibiotics are given preventatively. Other complications include Post-transplant lymphoproliferative disorder, a form of lymphoma due to the immune suppressants, and gastrointestinal inflammation and ulceration of the stomach and esophagus.

Transplant rejection is a primary concern, both immediately after the surgery and continuing throughout the patient's life. Because the transplanted lung or lungs come from another person, the recipient's immune system will see it as an invader and attempt to neutralize it. Transplant rejection is a serious condition and must be treated as soon as possible.

Signs of rejection:^[2]

• fever;
• flu-like symptoms, including chills, dizziness, nausea, general feeling of illness, night sweats;
• increased difficulty in breathing;
• worsening pulmonary test results;
• increased chest pain or tenderness;
• increase or decrease in body weight of more than two kilograms in a 24-hour period.

In order to prevent transplant rejection and subsequent damage to the new lung or lungs, patients must take a regimen of immunosuppressive drugs. Patients will normally have to take a combination of these medicines in order to combat the risk of rejection. This is a lifelong commitment, and must be strictly adhered to. The immunosuppressive regimen is begun just before or after surgery. Usually the regimen includes ciclosporin, azathioprine and corticosteroids, but as episodes of rejection may reoccur throughout a patient's life, the exact choices and dosages of immunosuppressants may have to be modified over time. Sometimes tacrolimus is given instead of ciclosporin and mycophenolate mofetil instead of azathioprine.

The immunosuppressants that are needed to prevent organ rejection also introduce some risks. By lowering the body's ability to mount an immune reaction, these medicines also increase the chances of infection. Antibiotics may be prescribed in order to treat or prevent such infections. In turn, infection may increase the risk of rejection, and generally an interaction may prevail between both risks.^[30] Certain medications may also have nephrotoxic or other potentially harmful side-effects. Other medications may also be prescribed in order to help alleviate these side effects. There is also the risk that a patient may have an allergic reaction to the medications. Close follow-up care is required in order to balance the benefits of these drugs versus their potential risks.

Chronic rejection, meaning repeated bouts of rejection symptoms beyond the first year after the transplant surgery, occurs in approximately 50% of patients.^[31] Such chronic rejection presents itself as bronchiolitis obliterans, or less frequently, atherosclerosis.^[31]

Prognosis

These statistics are based on data from 2008. The source data made no distinction between living and deceased donor organs, nor was any distinction made between lobar, single, and double lung transplants.^[32]

Survival rate after a lung transplant

	1 year survival	5 years survival	10 years survival
Lung transplant	83.6%	53.4%	28.4%
Heart-lung transplant	73.8%	46.5%	28.3%

Transplanted lungs typically last three to five years before showing signs of failure.

A 2019 cohort study of nearly 10,000 lung transplant recipients in the US demonstrated significantly improved long-term survival using sirolimus + tacrolimus (median survival 8.9 years) instead of mycophenolate mofetil + tacrolimus (median survival 7.1 years) for immunosuppressive therapy starting at one year after transplant. Since sirolimus is not administered until at least 3–12 months after transplant, these median survival estimates were conditional on surviving 1 year post-transplant.^[33] As lung transplantation has improved since the late 20th century with advancements in perioperative management, surgical technique and postoperative rehabilitation, 5-year survival has increased even up to 60-70%.^[34]

See also

• Sarah Murnaghan lung transplant controversy
• Post-transplant survival measure

References

1. Inci I (November 2020). "Lung transplantation for emphysema". Annals of Translational Medicine. 8 (21): 1473. doi:10.21037/atm-20-805. PMC 7723607. PMID 33313218.
2. "Lung Transplant". Aetna intelihealth. 30 January 2006. Archived from the original on 14 November 2006. Retrieved 29 September 2006.
3. Lung Transplant at eMedicine
4. Kern RM, Seethamraju H, Blanc PD, Sinha N, Loebe M, Golden J, et al. (July 2014). "The feasibility of lung transplantation in HIV-seropositive patients". Annals of the American Thoracic Society. 11 (6): 882–889. doi:10.1513/AnnalsATS.201402-083OC. PMC 4213997. PMID 24964265.
5. Metras H (1950). "Preliminary note on lung transplants in dogs". Comptes Rendus de l'Académie des Sciences. 231: 1176.
6. Hardy JD, Webb WR, Dalton ML, Walker GR (December 1963). "Lung Homotransplantation in Man". JAMA. 186 (12): 1065–1074. doi:10.1001/jama.1963.63710120001010. PMID 14061414.
7. "Transplanting Of Lung Apparently Successful", Tucson (AZ) Daily Citizen, June 13, 1963, p1
8. "History of Lung Transplantation". Emory University. 12 April 2005. Archived from the original on 2 October 2009. Retrieved 8 September 2009.
9. "Barnett To Free Killer Who Had Lung Transplant", Miami News, June 26, 1963, p3A
10. Cohen, DJ; Loertscher, R; Rubin, MF; Tilney, NL; Carpenter, CB; Strom, TB (November 1984). "Cyclosporine: a new immunosuppressive agent for organ transplantation". Annals of Internal Medicine. 101 (5): 667–82. doi:10.7326/0003-4819-101-5-667. PMID 6385799.
11. Reitz BA, Wallwork JL, Hunt SA, Pennock JL, Billingham ME, Oyer PE, et al. (March 1982). "Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease". The New England Journal of Medicine. 306 (10): 557–564. doi:10.1056/NEJM198203113061001. PMID 6799824.
12. Pulmonary Hypertension: A Patient's Survival Guide 3rd edition p. 126
13. Rundle RL (2 January 2003). "New Blood Procedure Helps Bolster Transplanted Lungs". The Wall Street Journal.
14. "First double-lung transplant recipient dies". Canadian Medical Association Journal. 164 (11). Canadian Medical Association: 1610. 29 May 2001. Retrieved 26 March 2008.
15. Hurley S (2018-11-20). "Longest surviving transplant recipient receives award". RTÉ News. Retrieved 2018-11-20.
16. Cullen P (2018-11-20). "Woman (77) who got new lung, kidney and hip is 'game for everything'". The Irish Times. Retrieved 2018-11-20.
17. "Sligo lung transplant recipient Vera Dwyer passes away 33 years after life-saving operation". Independent.ie. July 27, 2021.
18. Biscotti, M; Sonett, J; Bacchetta, M (2015). "ECMO as bridge to lung transplant". Thoracic Surgery Clinics. 25 (1): 17–25. doi:10.1016/j.thorsurg.2014.09.010. PMID 25430426.
19. Sef, D; Verzelloni Sef, A; Trkulja, V; Raj, B; Lees, NJ; Walker, C; Mitchell, J; Petrou, M; De Robertis, F; Stock, U; McGovern, I (April 2022). "Midterm outcomes of venovenous extracorporeal membrane oxygenation as a bridge to lung transplantation: Comparison with nonbridged recipients". Journal of Cardiac Surgery. 37 (4): 747–759. doi:10.1111/jocs.16253. PMID 35060184.
20. "Lung Transplant Evaluation: Required Tests". Cleveland Clinic. 7 February 2003. Archived from the original on 30 September 2007. Retrieved 29 September 2006.
21. Merlo, CA; Weiss, ES; Orens, JB; Borja, MC; Diener-West, M; Conte, JV; Shah, AS (August 2009). "Impact of U.S. Lung Allocation Score on survival after lung transplantation". The Journal of Heart and Lung Transplantation. 28 (8): 769–75. doi:10.1016/j.healun.2009.04.024. PMID 19632571.
22. Altman LK (13 May 1987). "In 3-Way Transplant, Living Patient Donates Heart". The New York Times. Retrieved 20 February 2008.
23. "What Is the Surgical Procedure?". American College of Chest Physicians. October 2005. Archived from the original on 25 September 2006. Retrieved 29 September 2006.
24. Taghavi, S; Bîrsan, T; Pereszlenyi, A; Kupilik, N; Deviatko, E; Wisser, W; Steltzer, H; Klepetko, W (May 1999). "Bilateral lung transplantation via two sequential anterolateral thoracotomies". European Journal of Cardio-Thoracic Surgery. 15 (5): 658–62. doi:10.1016/s1010-7940(99)00078-0. PMID 10386413.
25. Sef, D; Verzelloni Sef, A; Mohite, P; Stock, U; Trkulja, V; Raj, B; Garcia Saez, D; Mahesh, B; De Robertis, F; Simon, A (December 2020). "Utilization of extracorporeal membrane oxygenation in DCD and DBD lung transplants: a 2-year single-center experience". Transplant International. 33 (12): 1788–1798. doi:10.1111/tri.13754. PMID 32989785. S2CID 222162950.
26. Tarrant, BJ; Quinn, E; Robinson, R; Poulsen, M; Fuller, L; Snell, G; Thompson, BR; Button, BM; Holland, AE (3 July 2023). "Post-operative, inpatient rehabilitation after lung transplant evaluation (PIRATE): A feasibility randomized controlled trial". Physiotherapy Theory and Practice. 39 (7): 1406–1416. doi:10.1080/09593985.2022.2041779. PMID 35193445. S2CID 233532639.
27. Pulmonary Hypertension: A Patient's Survival Guide 3rd ed. p.134.
28. Pulmonary Hypertension: A Patient's Survival Guide 3rd ed. p. 133
29. Gutierrez-Arias R, Martinez-Zapata MJ, Gaete-Mahn MC, Osorio D, Bustos L, Melo Tanner J, et al. (July 2021). "Exercise training for adult lung transplant recipients". The Cochrane Database of Systematic Reviews. 2021 (7): CD012307. doi:10.1002/14651858.cd012307.pub2. PMC 8406964. PMID 34282853.
30. Bando K, Paradis IL, Komatsu K, Konishi H, Matsushima M, Keena RJ, et al. (January 1995). "Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation". The Journal of Thoracic and Cardiovascular Surgery. 109 (1): 49–59. doi:10.1016/S0022-5223(95)70419-1. PMID 7815807.
31. Merck Manual 18th ed. p. 1377
32. "2008 OPTN/SRTR Annual Report". US Scientific Registry of Transplant Recipients. 1 May 2008. Archived from the original on 5 June 2010. Retrieved 28 July 2010.
33. Wijesinha M, Hirshon JM, Terrin M, Magder L, Brown C, Stafford K, et al. (August 2019). "Survival Associated With Sirolimus Plus Tacrolimus Maintenance Without Induction Therapy Compared With Standard Immunosuppression After Lung Transplant". JAMA Netw Open. 2 (8): e1910297. doi:10.1001/jamanetworkopen.2019.10297. PMC 6716294. PMID 31461151.
34. Yang, Z; Takahashi, T; Terada, Y; Meyers, BF; Kozower, BD; Patterson, GA; Nava, RG; Hachem, RR; Witt, CA; Byers, DE; Kulkarni, HS; Guillamet, RV; Yan, Y; Chang, SH; Kreisel, D; Puri, V (December 2022). "A comparison of outcomes after lung transplantation between European and North American centers". The Journal of Heart and Lung Transplantation. 41 (12): 1729–1735. doi:10.1016/j.healun.2022.07.014. PMC 10305841. PMID 35970646.

Further reading

• Arcasoy, Selim M.; Kotloff, Robert M. (1999). "Lung Transplantation". N Engl J Med. 340 (14): 1081–1091. doi:10.1056/nejm199904083401406. PMID 10194239.

External links

• MedlinePlus Encyclopedia: Lung transplantation
• United Network for Organ Sharing
• International Society for Heart and Lung Transplantation
• Lung Transplant Foundation